Toshiaki Yoshikawa
- Immunology top 5%
- Immunotherapy and Immune Responses 34
- Immune Cell Function and Interaction 15
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 16
- CAR-T cell therapy research 14
-
- vaccines and immunoinformatics approaches 5
-
- Monoclonal and Polyclonal Antibodies Research 6
-
- Hepatitis B Virus Studies 5
- Co-authors
- Tetsuya NakatsuraItaru EndoDaisuke NobuokaYu SawadaShoichi MizunoToshihiro SuzukiManami ShimomuraYasuhiro Shimizu
- Cited by
- ImmunologyHepatologyOncology
- Journals
- Nucleic Acids Research (1 paper)SHILAP Revista de lepidopterología (1 paper)Blood (1 paper)
- Partner nations
- JapanUnited StatesTaiwan
In The Last Decade
Toshiaki Yoshikawa
50 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 73
- Immunology 752
- Hepatology 224
- Oncology 676
- Molecular Biology 564
- Cancer Research 117
Countries citing papers authored by Toshiaki Yoshikawa
This map shows the geographic impact of Toshiaki Yoshikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiaki Yoshikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiaki Yoshikawa more than expected).
Fields of papers citing papers by Toshiaki Yoshikawa
This network shows the impact of papers produced by Toshiaki Yoshikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiaki Yoshikawa. The network helps show where Toshiaki Yoshikawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Toshiaki Yoshikawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 4 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2020 | 7 | |
| 6 | 2016 | 13 | |
| 7 | 2015 | 17 | |
| 8 | 2015 | 30 | |
| 9 | 2014 | 9 | |
| 10 | 2014 | 67 | |
| 11 | 2014 | 19 | |
| 12 | 2014 | 16 | |
| 13 | 2013 | 22 | |
| 14 | 2013 | 21 | |
| 15 | 2013 | 14 | |
| 16 | 2012 | 251 | |
| 17 | 2011 | 66 | |
| 18 | 2011 | 20 | |
| 19 | 2008 | 0 | |
| 20 | 2007 | 22 |
About Toshiaki Yoshikawa
Toshiaki Yoshikawa is a scholar working on Immunology, Oncology and Hepatology, having authored 54 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (34 papers), Cancer Immunotherapy and Biomarkers (16 papers), Immune Cell Function and Interaction (15 papers), CAR-T cell therapy research (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), vaccines and immunoinformatics approaches (5 papers) and Hepatitis B Virus Studies (5 papers). The work is most often cited by research in Immunology (752 citations), Hepatology (224 citations) and Oncology (676 citations). Toshiaki Yoshikawa has collaborated with scholars based in Japan, United States and Taiwan. Frequent co-authors include Tetsuya Nakatsura, Itaru Endo, Daisuke Nobuoka, Yu Sawada, Shoichi Mizuno, Toshihiro Suzuki, Manami Shimomura, Yasuhiro Shimizu, Hirofumi Shirakawa and Shiro Suzuki. Their work appears in journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.